To be frank, I think anything would be sufficient as a starting point to gain universal access, if the provinces were all in alignment and in agreement to see it funded. Over time you would manage it, adjust it, and add more to it. You might leave opportunity for those very high-cost, supplementary kinds of medicines to be dealt with, with the deep insurance market that you have in North America. In fact, I think that Canada, in a sense, has greater opportunity here than New Zealand did to have universal access to a good range of products and at the same time keep access to some of these very specialized and high-cost treatments.
On February 14th, 2017. See this statement in context.